Patients with Low Drug Levels or Antibodies to a Prior Anti-TNF Are More Likely to Develop Antibodies to a Subsequent Anti-TNF

Eitemau Tebyg

• Use of anti-TNF drug levels to optimise patient management
  gan: Papamichael, Konstantinos, et al.
  Cyhoeddwyd: (2016)
• Assays for measurement of TNF antagonists in practice
  gan: Vande Casteele, Niels
  Cyhoeddwyd: (2017)
• Higher post-induction infliximab concentrations are associated with improved clinical outcomes in fistulizing Crohn’s disease: an ACCENT-II post-hoc analysis
  gan: Papamichael, Konstantinos, et al.
  Cyhoeddwyd: (2021)
• Defining and predicting deep remission in patients with perianal fistulizing Crohn’s disease on anti-tumor necrosis factor therapy
  gan: Papamichael, Konstantinos, et al.
  Cyhoeddwyd: (2017)
• Transmembrane TNF-dependent uptake of anti-TNF antibodies
  gan: Deora, Arun, et al.
  Cyhoeddwyd: (2017)